These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 15739714)

  • 1. Activated protein C in a pregnant patient with severe sepsis.
    Mahabeer N; Zwaal J
    Hosp Med; 2005 Feb; 66(2):124. PubMed ID: 15739714
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of recombinant human activated protein C in treatment of severe sepsis in a pregnant patient with fully symptomatic ovarian hyperstimulation syndrome.
    Mikaszewska-Sokolewicz M; Mayzner-Zawadzka E
    Med Sci Monit; 2005 Jun; 11(6):CS27-32. PubMed ID: 15917724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: a case report.
    Medve L; Csitári IK; Molnár Z; László A
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):864-5. PubMed ID: 16150290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second course of recombinant human activated protein C delivered to a severely septic patient after recent surgery.
    Lee SJ; Schuster R; Bindewald M; Greaney G; Waxman K
    J Trauma; 2008 May; 64(5):1370-2. PubMed ID: 17110881
    [No Abstract]   [Full Text] [Related]  

  • 5. [Exogenous activated protein C in severe sepsis].
    Mamontova OA; Protsenko DN; Eliutin DV; Kirienko PN; Gel'fand BR
    Anesteziol Reanimatol; 2005; (3):42-5. PubMed ID: 16076046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
    Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
    Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated protein C for the treatment of severe sepsis.
    Houston G; Cuthbertson BH
    Clin Microbiol Infect; 2009 Apr; 15(4):319-24. PubMed ID: 19416303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic recombinant murine activated protein C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumonia.
    Schouten M; van 't Veer C; van den Boogaard FE; Gerlitz B; Grinnell BW; Roelofs JJ; Levi M; van der Poll T
    J Infect Dis; 2010 Nov; 202(10):1600-7. PubMed ID: 20925531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis.
    Chawla LS; Seneff MG; Nelson DR; Williams M; Levy H; Kimmel PL; Macias WL
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):22-30. PubMed ID: 17699383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of severe sepsis with recombinant activated protein C during the third trimester of pregnancy.
    Gupta R; Strickland KM; Mertz HL
    Obstet Gynecol; 2011 Aug; 118(2 Pt 2):492-494. PubMed ID: 21768864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant human activated protein C (rhAPC) in the treatment of severe sepsis in immunosuppressed patients in the course of hematological diseases.
    Kunsdorf-Wnuk A; Marzec-Lewenstein E; Arct-Danielak D; Musioł E; Bohatyrewicz R; Becht R
    Med Sci Monit; 2005 Aug; 11(8):CS49-55. PubMed ID: 16049385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activated protein C in sepsis].
    Brandtzaeg P
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):766. PubMed ID: 15039802
    [No Abstract]   [Full Text] [Related]  

  • 13. Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results.
    Prescrire Int; 2007 Feb; 16(87):7-9. PubMed ID: 17323514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal outcome in patients with community-acquired pneumonia: Take the main course before the dessert.
    Rello J; Rodríguez A
    Crit Care Med; 2005 May; 33(5):1149. PubMed ID: 15891355
    [No Abstract]   [Full Text] [Related]  

  • 15. Complications of acute fatty liver of pregnancy treated with activated protein C.
    MacLean AA; Almeida Z; Lopez P
    Arch Gynecol Obstet; 2005 Dec; 273(2):119-21. PubMed ID: 16091940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired pneumonia in pregnancy.
    Sheffield JS; Cunningham FG
    Obstet Gynecol; 2009 Oct; 114(4):915-922. PubMed ID: 19888052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activated C protein in severe sepsis].
    Martynov AN; Gel'fand EB; Eliutin DV; Gel'fand BR
    Anesteziol Reanimatol; 2004; (4):50-1. PubMed ID: 15468558
    [No Abstract]   [Full Text] [Related]  

  • 18. [The distribution of sulfapyridazine in the organs of pregnant mice with generalized staphylococcal septicemia].
    Buniatova IM
    Farmakol Toksikol; 1973; 36(3):342-4. PubMed ID: 4788500
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced urinary estriol levels with erythromycin therapy.
    Gallagher JC; Ismail MA; Aladjem S
    Obstet Gynecol; 1980 Sep; 56(3):381-2. PubMed ID: 7422180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panel discussion of the treatment of serious Gram-negative infections.
    Fekety FR; Ohkoshi M; Geddes AM; Turck M
    Postgrad Med J; 1971 Feb; 47():Suppl:128-35. PubMed ID: 5556184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.